US Stem Cell Inc (USRM)

[Archery Class]

Logical conclusion and the same one I was thinking. Here we have an undervalued company with increasing revenues, on the right track to expansion, in an emerging industry that the public is about to dogpile on.

Think about it, stem cells can divide or self-renew indefinitely - which allows

.10 was just my short term, low expectation. I never expect dollarland or lunar satellite type of moves from things, but slow and steady.